NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 13 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $27,411,000 | +7.1% | 24,220,000 | -1.3% | 0.51% | +3.6% |
| Q2 2019 | $25,601,000 | +2.7% | 24,530,000 | -0.4% | 0.50% | -10.0% |
| Q1 2019 | $24,934,000 | +0.1% | 24,620,000 | -8.0% | 0.55% | -8.6% |
| Q4 2018 | $24,907,000 | -9.0% | 26,760,000 | -3.2% | 0.60% | +6.7% |
| Q3 2018 | $27,374,000 | -0.9% | 27,650,000 | +9.0% | 0.56% | -2.9% |
| Q2 2018 | $27,613,000 | -5.4% | 25,359,000 | -0.5% | 0.58% | +1.4% |
| Q1 2018 | $29,179,000 | +21.8% | 25,490,000 | +11.1% | 0.57% | +24.8% |
| Q4 2017 | $23,965,000 | +11.8% | 22,936,000 | +27.2% | 0.46% | +13.1% |
| Q3 2017 | $21,443,000 | +4.7% | 18,028,000 | -5.9% | 0.41% | +3.6% |
| Q2 2017 | $20,471,000 | +7.4% | 19,150,000 | +22.4% | 0.39% | +9.8% |
| Q1 2017 | $19,064,000 | +5.0% | 15,650,000 | -7.9% | 0.36% | +6.9% |
| Q4 2016 | $18,149,000 | +86.4% | 16,992,000 | +126.7% | 0.33% | +136.9% |
| Q3 2016 | $9,736,000 | +2.6% | 7,494,000 | -16.7% | 0.14% | -4.1% |
| Q2 2016 | $9,491,000 | – | 9,000,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 115,776,000 | $168,437,000 | 3.54% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,004,000 | $4,536,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,416,000 | $9,226,000 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 8,908,000 | $12,978,000 | 0.02% |
| Citadel Advisors | 29,066,000 | $42,190,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 3,200,000 | $4,614,176,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 919,000 | $1,341,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,681,000 | $9,762,000 | 0.00% |
| CREDIT SUISSE AG/ | 859,000 | $1,239,000 | 0.00% |
| MORGAN STANLEY | 470,000 | $680,000 | 0.00% |